Finnrick - Ensuring a Safer and More Transparent Supply Chain

Free peptides test: now with paid endotoxins contamination option

Qingdao Hongshengda Trading

Qingdao Hongshengda Trading

Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Qingdao Hongshengda Trading between 29 Jun 2025 and 5 Nov 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).

Finnrick Rating™
Tentative Rating
Qingdao Hongshengda Trading
Tirzepatide
Tested 4 Samples
Last test 5 Nov 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Qingdao Hongshengda Trading

Samples are tested in commercial labs

Tests Count

4

Scores

AVG6.5MIN2.0MAX10.0

Last

5 Nov 2025

First

29 Jun 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
5 Nov 2025View7.040mg47.28mg+18.2%99.80%07152025White Label / Silver Crimp / Clear Green CapLab GPublic
17 Oct 2025View10.060mg61.4mg+2.3%99.95%08152025White Label / Silver Crimp / Red Cap Lab EPublic
17 Oct 2025View2.040mg
⚠️ Sample does not contain Tirzepatide
07152025No Label / Silver Crimp / Clear Green Cap Lab EPublic
29 Jun 2025View7.130mg28.1mg-6.3%99.72%(no batch ID)No Label / Silver Crimp / Pink CapLab EPublic